Sudden cardiac death after acute decompensation in heart failure patients: implications of discharge haemoglobin levels.


Journal

ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191

Informations de publication

Date de publication:
10 2021
Historique:
revised: 27 04 2021
received: 28 11 2020
accepted: 29 04 2021
pubmed: 30 7 2021
medline: 29 10 2021
entrez: 29 7 2021
Statut: ppublish

Résumé

Heart failure (HF) patients have a high risk of mortality due to sudden cardiac death (SCD) and non-SCD, including pump failure death (PFD). Anaemia predicts more severe symptomatic burden and higher morbidity, as noted by markedly increased hospitalizations and readmission rates, and mortality, underscoring its importance in HF management. Herein, we aimed to determine whether haemoglobin (Hb) level at discharge affects the mode of death and influences SCD risk prediction. We evaluated the data of 3020 consecutive acute HF patients from a Japanese prospective multicentre registry. Patients were divided into four groups based on discharge Hb levels. SCD was defined as an unexpected and otherwise unexplained death in a previously stable patient or death due to documented or presumed cardiac arrhythmia without a clear non-cardiovascular cause. The mode of death (SCD, PFD or other cause) was adjudicated by a central committee. Finally, we investigated whether adding Hb level to the Seattle Proportional Risk Model (SPRM; established risk score utilized to estimate 'proportion' of SCD among death events) would affect its performance. The mean age of studied patients was 74.3 ± 12.9 years, and 59.8% were male. The mean Hb level was 12.0 ± 2.1 g/dL (61.3% of patients had anaemia defined by World Health Organization criteria). During the 2-year follow-up, 474 deaths (15.7%) occurred, including 93 SCDs (3.1%), 171 PFDs (5.7%) and 210 other deaths (7.0%; predominantly non-cardiac death). Absolute risk of PFD (P < 0.001) or other death (P < 0.001) increased along with the severity of anaemia, whereas the incidence of SCD was low but remained consistent across all four groups (P = 0.440). As a proportion of total deaths in each Hb level group, the contributions from non-SCD increased and from SCD decreased along with anaemia severity (P = 0.007). Adding Hb level to the SPRM improved the overall discrimination (c-index: 0.62 [95% confidence interval (CI) 0.56-0.69] to 0.65 [95% CI 0.59-0.71]), regardless of the baseline ejection fraction (EF) (c-index: 0.64 [95% CI 0.55-0.73] to 0.67 [95% CI 0.58-0.75] for reduced EF and 0.55 [95% CI 0.45-0.66] to 0.61 [95% CI 0.52-0.70] for preserved EF). The discharge Hb level provides information about both absolute and proportional risks for each mode of death in acute HF patients, and the addition of Hb level improves the performance of SPRM by identifying more non-SCD cases. Future 'proportional' SCD risk models should incorporate Hb level as a covariate to meet this high performance.

Identifiants

pubmed: 34323007
doi: 10.1002/ehf2.13414
pmc: PMC8497203
doi:

Substances chimiques

Hemoglobins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3917-3928

Informations de copyright

© 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

Références

JACC Heart Fail. 2020 Sep;8(9):725-738
pubmed: 32800509
J Am Coll Cardiol. 2015 Jul 28;66(4):403-69
pubmed: 25553722
N Engl J Med. 2017 Jul 6;377(1):41-51
pubmed: 28679089
ESC Heart Fail. 2021 Oct;8(5):3917-3928
pubmed: 34323007
Circulation. 2006 Jun 13;113(23):2713-23
pubmed: 16754803
J Am Coll Cardiol. 2018 Oct 2;72(14):e91-e220
pubmed: 29097296
Circulation. 2006 Mar 21;113(11):1424-33
pubmed: 16534009
J Am Heart Assoc. 2018 Sep 18;7(18):e008687
pubmed: 30371201
Circulation. 2019 Nov 5;140(19):1530-1539
pubmed: 31476893
Am J Cardiol. 2020 Aug 15;129:46-52
pubmed: 32563496
Eur J Heart Fail. 2020 Jan;22(1):81-89
pubmed: 31793144
Circulation. 2003 Jan 21;107(2):223-5
pubmed: 12538418
Europace. 2020 Apr 1;22(4):588-597
pubmed: 32155253
JACC Heart Fail. 2018 Mar;6(3):201-208
pubmed: 29128254
Circ Arrhythm Electrophysiol. 2012 Aug 1;5(4):706-13
pubmed: 22685111
Circulation. 2007 Jul 24;116(4):392-8
pubmed: 17620506
Heart Rhythm. 2015 Oct;12(10):2069-77
pubmed: 26142301
Circulation. 2004 Jul 13;110(2):149-54
pubmed: 15210591
Circulation. 1993 Jul;88(1):107-15
pubmed: 8319323
Int J Cardiol. 2018 Jan 1;250:164-170
pubmed: 29169753
N Engl J Med. 2005 Jan 20;352(3):225-37
pubmed: 15659722
Circ J. 2015;79(2):381-90
pubmed: 25476195
World Health Organ Tech Rep Ser. 1968;405:5-37
pubmed: 4975372
N Engl J Med. 2002 Mar 21;346(12):877-83
pubmed: 11907286
Circulation. 2014 Mar 25;129(12):1286-94
pubmed: 24515993
JACC Clin Electrophysiol. 2017 Mar;3(3):291-298
pubmed: 28553663
J Card Fail. 2006 Mar;12(2):100-7
pubmed: 16520256
Circulation. 2017 Aug 8;136(6):e137-e161
pubmed: 28455343
Eur Heart J. 2009 May;30(9):1088-96
pubmed: 19240065
Circ J. 2012;76(7):1662-9
pubmed: 22481105
J Am Coll Cardiol. 2003 Jun 4;41(11):1933-9
pubmed: 12798560
ESC Heart Fail. 2018 Aug;5(4):570-578
pubmed: 29604185
Int Urol Nephrol. 2006;38(2):295-310
pubmed: 16868702
Am J Kidney Dis. 2002 Feb;39(2 Suppl 1):S1-266
pubmed: 11904577
N Engl J Med. ;377(18):1794
pubmed: 29094861

Auteurs

Ryoma Fukuoka (R)

Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.
Department of Cardiology, International University of Health and Welfare, School of Medicine, Chiba, Japan.

Shun Kohsaka (S)

Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.

Yasuyuki Shiraishi (Y)

Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.

Mitsuaki Sawano (M)

Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.

Takayuki Abe (T)

School of Data Science, Yokohama City University, Yokohama, Japan.

Wayne C Levy (WC)

Division of Cardiology, University of Washington, Seattle, WA, USA.

Yuji Nagatomo (Y)

Department of Cardiology, National Defense Medical College, Tokorozawa, Japan.

Yosuke Nishihata (Y)

Department of Cardiology, Cardiovascular Centre, St. Luke's International Hospital, Tokyo, Japan.

Ayumi Goda (A)

Department of Cardiovascular Medicine, Kyorin University School of Medicine, Tokyo, Japan.

Takashi Kohno (T)

Department of Cardiovascular Medicine, Kyorin University School of Medicine, Tokyo, Japan.

Akio Kawamura (A)

Department of Cardiology, International University of Health and Welfare, School of Medicine, Chiba, Japan.

Keiichi Fukuda (K)

Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.

Tsutomu Yoshikawa (T)

Department of Cardiology, Sakakibara Heart Institute, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH